Qian Zhao MD

Physician

Summary

Dr. Qian Zhao is a cardiologist based in Flushing, NY, and has been serving as an attending physician at St. Francis Hospital and Heart Center since 2012. She completed her internal medicine residency at Richmond University Medical Center and a fellowship in cardiovascular disease at SUNY Downstate Health Sciences University. Dr. Zhao's medical education began at the Fourth Military Medical University. She has been recognized as a Fellow of the American College of Cardiology. In addition to her expertise in general cardiology, she has contributed to several research publications focused on HIV entry inhibitors from 2002 to 2005.

SUNY Downstate Health Sciences UniversityFellowship, Cardiovascular Disease, 2009 - 2012
Westchester Medical CenterResidency, Internal Medicine, 2006 - 2009
Fourth Military Medical University Class of 1995

Journal Articles

Peptide and non-peptide HIV fusion inhibitors.
Jiang S, Zhao Q, Debnath AK., Curr Pharm Des. 2002;8(8):563-80.
XTT formazan widely used to detect cell viability inhibits HIV type 1 infection in vitro by targeting gp41.
Zhao Q, Ernst JT, Hamilton AD, Debnath AK, Jiang S., AIDS Res Hum Retroviruses. 2002 Sep 20;18(14):989-97.
Development of a cell-based enzyme-linked immunosorbent assay for high-throughput screening of HIV type 1 entry inhibitors targeting the coreceptor CXCR4.
Zhao Q, Lu H, Schols D, De Clercq E, Jiang S., AIDS Res Hum Retroviruses. 2003 Nov;19(11):947-55.
A novel assay to identify entry inhibitors that block binding of HIV-1 gp120 to CCR5.
Zhao Q, He Y, Alespeiti G, Debnath AK., Virology. 2004 Sep 1;326(2):299-309.
Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.
Zhao Q, Ma L, Jiang S, Lu H, Liu S, He Y, Strick N, Neamati N, Debnath AK., Virology. 2005 Sep 1;339(2):213-25
Join now to see all

Surgical Treatment of Pulmonary Artery Sarcoma: A Report of 17 CasesJanuary 20th, 2021
MEF2A-Mediated lncRNA HCP5 Inhibits Gastric Cancer Progression via MiR-106b-5p/p21 AxisDecember 31st, 2020